Clinical trial · Interventional
Interest of Auriculotherapy in the Treatment of Xerostomia
Interest of Auriculotherapy in the Treatment of Xerostomia.
NCT04222478CI-TRIAL-00114467AURICULOXEROcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to show that auriculotherapy is effective in the treatment of xerostomia
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Xerostomia | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-specific auriculotherapy | Other | — | UNRESOLVED |
| Specific auriculotherapy | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Real Auriculotherapy
- description
- Patients benefit from 3 sessions of auriculotherapy with semi-permanent needles on the 6 points according to the "protocol of Alimi" at one month intervals.
- interventionNames
- Other: Specific auriculotherapy
- type
- SHAM_COMPARATOR
- label
- Sham Auriculotherapy
- description
- Patients are treated according to the same scheme as the experimental group but with semi-permanent needles positioned on non-specific points.
- interventionNames
- Other: Non-specific auriculotherapy
Primary outcomes (1)
- measure
- Number of patients with improvement of salivation after 3 month of treatment (Real Auriculotherapy group compared to Sham Auriculotherapy group)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients over 18 years old; * Complain about xerostomia after cervical irradiation in the context of ENT cancer; * End of radiotherapy\> 3 months * Covered by a national healthcare insurance * Consent form signed. Non inclusion Criteria: * Pregnant or breastfeeding women; * Local counterindication to auriculotherapy; * With anticoagulant treatment; * History or existing of hemophilia; * Valvular prosthesis; * Ear's pavilion infection; * Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months; * Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management); * Difficulty to comply with the treatment, questionnaires or study protocol; * Being deprived of liberty or under guardianship.
References
Publications (0)
Data not yet available
No reference posted for this study.